HUMACYTE INC
HUMA·44486Q103·US·Common Stock·Healthcare - Biotechnology-Activist
HUMA (HUMACYTE INC) is held by 83 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($7.9M), Alyeska Investment Group, L.P. ($4.7M), BlackRock, Inc. ($3.8M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 48 funds bought HUMA.
83
Holders
(8 Elite)
$37.2M
Total Value
51% (94)
Consensus
48 buying - 46 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 9, 2026 · Insiders Sep 15, 2026 · Activists Jul 28, 2026 · Congress Aug 5, 2026
InsiderJAJones Keith AnthonyBuy $6KSep 14, 2026
InsiderJAJones Keith AnthonyBuy $7KAug 20, 2026
InsiderJAJones Keith AnthonyBuy $18KAug 17, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 102
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
416 holders · $299.1B
415 holders · $877.5B
400 holders · $151.4B
397 holders · $414.1B
394 holders · $97.5B
393 holders · $111.5B
390 holders · $230.1B
385 holders · $302.9B
385 holders · $51.8B
382 holders · $113.8B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer